1
|
Tejera-Vaquerizo A, Boada A, Puig S, Nagore E, Fernández-de-Misa R, Ferrándiz L, Conde-Taboada A, Castro E, Richarz NA, Paradela S, Llambrich Á, Salgüero I, Diago A, Samaniego E, Flórez Á, Segura S, Maldonado-Seral C, Coronel-Pérez IM, Tomás-Velázquez A, Rodríguez P, Mayor A, García-Doval I, Grau-Pérez M. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation. Actas Dermosifiliogr 2024:S0001-7310(24)00184-4. [PMID: 38452890 DOI: 10.1016/j.ad.2024.02.027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/06/2023] [Revised: 01/24/2024] [Accepted: 02/25/2024] [Indexed: 03/09/2024] Open
Abstract
INTRODUCTION The incidence of melanoma is rising in Spain. The prognostic stages of patients with melanoma are determined by various biological factors, such as tumor thickness, ulceration, or the presence of regional or distant metastases. The Spanish Academy of Dermatology and Venereology (AEDV) has encouraged the creation of a Spanish Melanoma Registry (REGESMEL) to evaluate other individual and health system-related factors that may impact the prognosis of patients with melanoma. The aim of this article is to introduce REGESMEL and provide basic descriptive data for its first year of operation. METHODS REGESMEL is a prospective, multicentre cohort of consecutive patients with invasive cutaneous melanoma that collects demographic and staging data as well as individual and healthcare-related baseline data. It also records the medical and surgical treatment received by patients. RESULTS A total of 450 cases of invasive cutaneous melanoma from 19 participant centres were included, with a predominance of thin melanomas≤1mm thick (54.7%), mainly located on the posterior trunk (35.2%). Selective sentinel lymph node biopsy was performed in 40.7% of cases. Most cases of melanoma were suspected by the patient (30.4%), or his/her dermatologist (29.6%). Patients received care mainly in public health centers (85.2%), with tele-dermatology resources being used in 21.6% of the cases. CONCLUSIONS The distribution of the pathological and demographic variables of melanoma cases is consistent with data from former studies. REGESMEL has already recruited patients from 15 Spanish provinces and given its potential representativeness, it renders the Registry as an important tool to address a wide range of research questions.
Collapse
Affiliation(s)
| | - A Boada
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, España
| | - S Puig
- Servicio de Dermatología, Hospital Clínic de Barcelona, IDIBAPS, Universidad de Barcelona, Barcelona, España; Centro de investigación biomédica en red de enfermedades raras, CIBERER, Barcelona, España
| | - E Nagore
- Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España
| | - R Fernández-de-Misa
- Servicio de Dermatología, Hospital Universitario Nuestra Señora de Candelaria, Santa Cruz de Tenerife, España
| | - L Ferrándiz
- Unidad de Melanoma, Servicio de Dermatología médico-quirúrgico, Hospital Universitario Virgen Macarena, Sevilla, España
| | - A Conde-Taboada
- Servicio de Dermatología, Hospital Clínico San Carlos, Madrid, España
| | - E Castro
- Servicio de Dermatología, Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, España
| | - N A Richarz
- Servicio de Dermatología, Hospital Universitari Germans Trias i Pujol, Institut d'Investigació Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, España
| | - S Paradela
- Servicio de Dermatología, Complexo Hospitalario A Coruña, A Coruña, España
| | - Á Llambrich
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma de Mallorca, España
| | - I Salgüero
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, España
| | - A Diago
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - E Samaniego
- Servicio de Dermatología, Complejo Asistencial Universitario de León, León, España
| | - Á Flórez
- Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Grupo de Investigación DIPO, Instituto de Investigación Sanitaria Galicia Sur, SERGAS-UVIGO, Pontevedra, España
| | - S Segura
- Servicio de Dermatología, Hospital del Mar de Barcelona, Barcelona, España
| | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, España
| | - I M Coronel-Pérez
- Servicio de Dermatología, Hospital Universitario Virgen de Valme de Sevilla, Sevilla, España
| | - A Tomás-Velázquez
- Servicio de Dermatología, Clínica Universidad de Navarra, Madrid, España
| | - P Rodríguez
- Servicio de Dermatología, Hospital Universitario La Princesa, Madrid, España; Servicio de Dermatología, Hospital Ruber Internacional, Madrid, España
| | - A Mayor
- Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Servicio de Dermatología, Complexo Hospitalario Universitario de Vigo, Vigo, España
| | - M Grau-Pérez
- Unidad de Investigación, Academia Española de Dermatología y Venereología, Madrid, España; Universidad de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, España.
| |
Collapse
|
2
|
Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, Pasquali P, Aguado Vázquez Á, Masferrer E, Rodríguez González L, Ruiz-Sánchez D, Caballero-Linares CF, Tejera-Vaquerizo A, Iglesias-Pena N, Fernández de Piérola S, Maldonado-Seral C, Armengot-Carbó M, Alonso-Naranjo L, Barros Tornay R, Solano Novo T, Fernández Tapia V, Martín-Gorgojo A, Adsuar Mas J, Parera Amer ME, Pérez Feal P, Taberner R, Utrera-Busquets M, Vicente Sánchez I, Palacio Aller L, Sánchez-Gutiérrez I, Usero-Bárcena T, Aldea Manrique B, Sánchez Velázquez A, Martínez García E, Grau-Pérez M, García-Doval I. Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermosifiliogr 2024; 115:36-47. [PMID: 37678633 DOI: 10.1016/j.ad.2023.08.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Revised: 08/22/2023] [Accepted: 08/28/2023] [Indexed: 09/09/2023] Open
Abstract
BACKGROUND Several studies support the hypothesis that scabies is on the rise in Spain. There are also concerns about the possible development of resistance to treatment and an increase in atypical presentations. The aims of this study were to describe the demographic and clinical characteristics of patients with scabies seen by dermatologists in Spain, to identify the possible emergence of atypical forms of scabies, and to explore the frequency of treatment failures and associated risk factors. METHODS We conducted an observational, cross-sectional, multicenter study of data collected prospectively in April and May 2023 using the CLINI-AEDVp platform created by the Spanish Academy of Dermatology and Venereology (AEDV). RESULTS Participating dermatologists from 31 hospitals in 15 of Spain's autonomous communities recorded 186 cases of active scabies (51% in women) during the study period. A diagnostic certainty level of A, B or C as per the International Alliance for the Control of Scabies Consensus Criteria was required for diagnosis. Overall, 92% of patients had typical scabies and 66% had already been treated with a scabicide for the current episode. Of the treated patients, only 36% had received and completed adequate treatment (including the simultaneous treatment of all household members) and 50% had not received clear written recommendations. CONCLUSIONS In a high proportion of the cases of scabies studied, the patient had already received treatment. In those cases, we observed several remediable shortcomings that could explain why some of these treatments had failed. Remedying these deficiencies should lead to better control of scabies and an improved assessment of the actual effectiveness of currently available scabicides.
Collapse
Affiliation(s)
- C Galván Casas
- Unidad de Investigación STI & NTD, Fundación Lucha contra las Infecciones, Badalona, Barcelona, España; Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Prados-Carmona
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Fernández Camporro
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | | | - P Pasquali
- Centro Médico Pasquali & Asociados, Cambrils, Tarragona, España
| | - Á Aguado Vázquez
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | | | - D Ruiz-Sánchez
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - C F Caballero-Linares
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, España
| | | | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
| | - M Armengot-Carbó
- Servicio de Dermatología, Hospital General Universitario de Castellón, Castellón, España
| | | | - R Barros Tornay
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | - V Fernández Tapia
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - A Martín-Gorgojo
- Servicio ITS/Dermatología, Sección Especialidades Médicas, Ayuntamiento de Madrid, Madrid, España
| | - J Adsuar Mas
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - M E Parera Amer
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - P Pérez Feal
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - R Taberner
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | | | - I Vicente Sánchez
- Organización sanitaria Integrada Barrualde-Galdakao, Vizcaya, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - I Sánchez-Gutiérrez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | - T Usero-Bárcena
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - B Aldea Manrique
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - A Sánchez Velázquez
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - E Martínez García
- Servicio de Dermatología, Hospital Universitario Virgen de la Victoria, Málaga, España
| | - M Grau-Pérez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España; Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España.
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España
| |
Collapse
|
3
|
Galván Casas C, Ruiz-Villaverde R, Prados-Carmona Á, Fernández Camporro Á, Angulo Menéndez AG, Álvarez-Buylla Puente MC, Pasquali P, Aguado Vázquez Á, Masferrer E, Rodríguez González L, Ruiz-Sánchez D, Caballero-Linares CF, Tejera-Vaquerizo A, Iglesias-Pena N, Fernández de Piérola S, Maldonado-Seral C, Armengot-Carbó M, Alonso-Naranjo L, Barros Tornay R, Solano Novo T, Fernández Tapia V, Martín-Gorgojo A, Adsuar Mas J, Parera Amer ME, Pérez Feal P, Taberner R, Utrera-Busquets M, Vicente Sánchez I, Palacio Aller L, Sánchez-Gutiérrez I, Usero-Bárcena T, Aldea Manrique B, Sánchez Velázquez A, Martínez García E, Grau-Pérez M, García-Doval I. [Translated article] Clinical and Epidemiological Characteristics of Patients Being Treated for Scabies in Spain: Opportunities for Improvement - A Multicenter Cross-Sectional CLINI-AEDV Study. Actas Dermo-Sifiliográficas 2024; 115:T36-T47. [PMID: 37923079 DOI: 10.1016/j.ad.2023.10.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/28/2023] [Accepted: 08/28/2023] [Indexed: 11/07/2023] Open
Abstract
BACKGROUND Several studies support the hypothesis that scabies is on the rise in Spain. There are also concerns about the possible development of resistance to treatment and an increase in atypical presentations. The aims of this study were to describe the demographic and clinical characteristics of patients with scabies seen by dermatologists in Spain, to identify the possible emergence of atypical forms of scabies, and to explore the frequency of treatment failures and associated risk factors. METHODS We conducted an observational, cross-sectional, multicenter study of data collected prospectively in April and May 2023 using the CLINI-AEDVp platform created by the Spanish Academy of Dermatology and Venereology (AEDV). RESULTS Participating dermatologists from 31 hospitals in 15 of Spain's autonomous communities recorded 186 cases of active scabies (51% in women) during the study period. A diagnostic certainty level of A, B or C as per the International Alliance for the Control of Scabies Consensus Criteria was required for diagnosis. Overall, 92% of patients had clinical features of classic scabies and 66% had already been treated with a scabicide for the current episode. Of the treated patients, only 36% had received and completed adequate treatment (including the simultaneous treatment of all household members) and 50% had not received clear written recommendations. CONCLUSIONS In a high proportion of scabies cases, the patient has already received treatment. In those cases, we observe several remediable shortcomings that could explain why some of these treatments fail. Remedying these deficiencies should lead to better control of scabies and an improved assessment of the actual effectiveness of currently available scabicides.
Collapse
Affiliation(s)
- C Galván Casas
- Unidad de Investigación STI & NTD, Fundación Lucha contra las Infecciones, Badalona, Barcelona, España; Servicio de Dermatología, Hospital Universitario de Móstoles, Móstoles, Madrid, España
| | - R Ruiz-Villaverde
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Prados-Carmona
- Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, España
| | - Á Fernández Camporro
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | | | - P Pasquali
- Centro Médico Pasquali & Asociados, Cambrils, Tarragona, España
| | - Á Aguado Vázquez
- Servicio de Dermatología, Hospital Universitario Doctor Peset, Valencia, España
| | | | | | - D Ruiz-Sánchez
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - C F Caballero-Linares
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | | | - N Iglesias-Pena
- Servicio de Dermatología, Hospital San Rafael, A Coruña, España
| | | | - C Maldonado-Seral
- Servicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España
| | - M Armengot-Carbó
- Servicio de Dermatología, Hospital General Universitario de Castellón, Castellón, España
| | | | - R Barros Tornay
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | | | - V Fernández Tapia
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - A Martín-Gorgojo
- Servicio ITS/Dermatología, Sección Especialidades Médicas, Ayuntamiento de Madrid, Madrid, España
| | - J Adsuar Mas
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - M E Parera Amer
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | - P Pérez Feal
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - R Taberner
- Servicio de Dermatología, Hospital Universitario Son Llàtzer, Palma, Palma de Mallorca, España
| | | | - I Vicente Sánchez
- Organización sanitaria Integrada Barrualde-Galdakao, Vizcaya, España
| | - L Palacio Aller
- Servicio de Dermatología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - I Sánchez-Gutiérrez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España
| | - T Usero-Bárcena
- Servicio de Dermatología, Hospital Universitario Lucus Augusti, Lugo, España
| | - B Aldea Manrique
- Servicio de Dermatología, Hospital Universitario Miguel Servet, Zaragoza, España
| | - A Sánchez Velázquez
- Servicio de Dermatología, Hospital Universitario 12 de Octubre, Madrid, España
| | - E Martínez García
- Servicio de Dermatología, Hospital Universitario Virgen de la Victoria, Málaga, España
| | - M Grau-Pérez
- Servicio de Dermatología, Hospital Universitario Puerta de Hierro-Majadahonda, Majadahonda, Madrid, España; Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España.
| | - I García-Doval
- Unidad de Investigación, Academia Española de Dermatología y Venereología (AEDV), Madrid, España
| |
Collapse
|
4
|
Coto-Segura P, Eiris-Salvado N, González-Lara L, Queiro-Silva R, Martinez-Camblor P, Maldonado-Seral C, García-García B, Palacios-García L, Gomez-Bernal S, Santos-Juanes J, Coto E. Psoriasis, psoriatic arthritis and type 2 diabetes mellitus: a systematic review and meta-analysis. Br J Dermatol 2013; 169:783-93. [DOI: 10.1111/bjd.12473] [Citation(s) in RCA: 101] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/10/2013] [Indexed: 12/14/2022]
Affiliation(s)
- P. Coto-Segura
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
- Unit of Psoriasis; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - N. Eiris-Salvado
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
- Unit of Psoriasis; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - L. González-Lara
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - R. Queiro-Silva
- Unit of Psoriasis; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
- Rheumatology Department ; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - P. Martinez-Camblor
- Oficina de Investigación Biosanitaria de Asturias and Statistical Department; Oviedo University; 33006 Oviedo Asturias Spain
| | - C. Maldonado-Seral
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - B. García-García
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - L. Palacios-García
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - S. Gomez-Bernal
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - J. Santos-Juanes
- Dermatology Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| | - E. Coto
- Unit of Psoriasis; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
- Molecular Genetics Department; Hospital Universitario Central de Asturias; 33006 Oviedo Asturias Spain
| |
Collapse
|
5
|
Vázquez-López F, Maldonado-Seral C, Soler-Sánchez T, Perez-Oliva N, Marghoob AA. Surface microscopy for discriminating between common urticaria and urticarial vasculitis. Rheumatology (Oxford) 2003; 42:1079-82. [PMID: 12730524 DOI: 10.1093/rheumatology/keg301] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
BACKGROUND Urticarial vasculitis is a clinicopathological entity that overlaps with common urticaria, and biopsy is required for differentiation between them. OBJECTIVE To determine, for the first time, if skin surface microscopy can aid in the clinical differentiation between common urticaria and urticarial vasculitis in daily practice. PATIENTS AND METHODS Lesions in 20 consecutive patients with a clinical diagnosis of urticaria were studied by biopsy and skin surface microscopy (10x dermoscope) after covering the lesions with olive oil. Lesions were photographed with Dermaphot equipment. A biopsy was taken from all patients. Statistical analysis included Fisher's exact test and Cohen kappa statistics (intra-observer reproducibility). RESULTS Two dermoscopic patterns were observed: (i). a red-lined vascular pattern (17/20 patients); and (ii). a purpuric globular pattern (3/20 patients). Leucocytoclastic vasculitis was demonstrated histologically in all lesions presenting purpuric globules (3/3) but in none of the lesions presenting a dermoscopic red-lined pattern (P < 0.0008). The intra-observer reproducibility for scoring the red lines and purpuric globules was excellent (kappa=0.8). CONCLUSION The results of this pilot study suggest that skin surface microscopy, using a 10x dermoscope, detects purpuric globules in urticarial lesions, and that purpuric globules indicate underlying leucocytoclastic vasculitis.
Collapse
Affiliation(s)
- F Vázquez-López
- Department of Dermatology, Centrak University Hospital, University of Oviedo, Oviedo, Spain.
| | | | | | | | | |
Collapse
|
6
|
|